Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries

@article{Mendelson2016MaximisingAT,
  title={Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries},
  author={Marc Mendelson and John-Arne R{\o}ttingen and Unni Gopinathan and Davidson H. Hamer and Heiman F. L. Wertheim and Buddha Basnyat and Chris Butler and G{\"o}ran Tomson and Manica Balasegaram},
  journal={The Lancet},
  year={2016},
  volume={387},
  pages={188-198}
}
Access to quality-assured antimicrobials is regarded as part of the human right to health, yet universal access is often undermined in low-income and middle-income countries. Lack of access to the instruments necessary to make the correct diagnosis and prescribe antimicrobials appropriately, in addition to weak health systems, heightens the challenge faced by prescribers. Evidence-based interventions in community and health-care settings can increase access to appropriately prescribed… Expand

Topics from this paper

Addressing antimicrobial resistance by improving access and quality of care—A review of the literature from East Africa
TLDR
It is argued that major inadequacies exist across all 6 dimensions of access and quality of drugs and their provision, and advocated for a holistic approach to tackling these inadequacies, encompassing all dimensions of Access and Quality of healthcare in order to improve health outcomes while simultaneously counteracting the AMR crisis. Expand
Antimicrobial Stewardship in Low- and Middle-Income Countries
TLDR
AMS programs must be present in all scenarios and should be context- and culture-adapted, balancing effectiveness and cost of different strategies, according to local epidemiology and bacterial resistance. Expand
Assessing and improving rational antimicrobial use in urban and rural health care facilities in Vietnam
TLDR
Antimicrobial use in Vietnam is largely uncontrolled both in the community and the healthcare system leading to overuse and over-prescription for non-severe ARI, and proper funding mechanisms to balance the invested costs and achieve global impact on AMR is recommended. Expand
Access to effective antimicrobials: a worldwide challenge
TLDR
The disease burden caused by limited access to antimicrobials, attributable to resistance to antimicrobial resistance, and the potential effect of vaccines in restricting the need for antibiotics are assessed. Expand
Advocacy for Increased International Efforts for Antimicrobial Stewardship Actions in Low-and Middle-Income Countries on Behalf of Alliance for the Prudent Use of Antimicrobials (APUA), Under the Auspices of the International Society of Antimicrobial Chemotherapy (ISAC)
TLDR
Despite the need to individually tailor AMS programs in LMIC, international collaborations remain highly valuable, through the dissemination of high-quality documents and educational material that may be shared, adapted where needed, and adopted worldwide. Expand
International cooperation to improve access to and sustain effectiveness of antimicrobials
TLDR
Policy makers are called on to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action to improve access to life-saving antimicrobials. Expand
Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach
TLDR
Contextual complexities and differences between countries with different incomes, policy frameworks, and cultural norms render a single strategy inadequate and instead necessitate context-tailored, integrated intervention packages to improve antibiotic use in LMICs as part of global efforts to combat antibiotic resistance. Expand
National action for global gains in antimicrobial resistance
TLDR
In the Lancet Series on antimicrobial access, sustainability, and sustainability, Ramanan Laxminarayan and colleagues make the case that far more people die from lack of access to antibiotics than from antimicrobial resistance, and estimate that 75% of community-acquired pneumonia deaths in children younger than 5 years could be averted by universal access toiotics. Expand
Antibiotic stewardship in low- and middle-income countries: the same but different?
  • J. Cox, E. Vlieghe, +5 authors G. Levy Hara
  • Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2017
TLDR
This work highlights challenges for ABS initiatives in LMICs, gives an outline of (inter)national recommendations and demonstrates examples of effective, contextualized stewardship interventions. Expand
Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries
TLDR
This work proposes new approaches that address emerging, One Health challenges, and considers the growing impact of animal and environmental reservoirs of antibiotic resistance, which threaten to exacerbate the antibiotic resistance crisis in LMICs. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 118 REFERENCES
International cooperation to improve access to and sustain effectiveness of antimicrobials
TLDR
Policy makers are called on to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action to improve access to life-saving antimicrobials. Expand
Improving antibiotic use in low-income countries: an overview of evidence on determinants.
TLDR
This review provides information from studies on the factors that influence the use of antibiotics by health providers, dispensers and community members in low-income countries and explores in more depth the socio-cultural rationality of antibiotic usage. Expand
Improving antimicrobial use among health workers in first-level facilities: results from the multi-country evaluation of the Integrated Management of Childhood Illness strategy.
TLDR
IMCI case management training is an effective intervention to improve the rational use of antimicrobial drugs for sick children visiting first-level health facilities in low-income and middle-income countries. Expand
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries.
TLDR
Although the most effective interventions and potential adverse outcomes remain unclear, public campaigns can probably contribute to more careful use of antibiotics in outpatients, at least in high-prescribing countries. Expand
Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam
TLDR
A situation analysis of the current patterns and determinants of antibiotic use and resistance in Viet Nam focusing on the healthcare system, drug regulation and supply; antibiotic resistance and infection control; and agricultural antibiotic use finds that future legislation regarding antibiotic access must alter incentives for purchasers and providers and ensure effective enforcement. Expand
Current initiatives to improve prudent antibiotic use amongst school-aged children.
TLDR
An overview of some initiatives aimed at limiting the extent of inappropriate antibiotic use in children are provided. Expand
Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India
TLDR
A qualitative study was conducted to understand the dispensing practices and behaviour of community pharmacists to develop policy interventions that would improve the use of antibiotics at the community level. Expand
Interventions to improve antibiotic prescribing practices in ambulatory care.
TLDR
Multi-faceted interventions combining physician, patient and public education in a variety of venues and formats were the most successful in reducing antibiotic prescribing for inappropriate indications. Expand
Exploring the evidence base for national and regional policy interventions to combat resistance
TLDR
This work examines three policy domains-responsible use, surveillance, and infection prevention and control-and considers which will be the most effective at national and regional levels, calling for comprehensive policy assessments, using standardised frameworks, of cost-effectiveness and generalisability. Expand
From Financing to Fevers: Lessons of an Antimalarial Subsidy Program
TLDR
Although resistance to artemisinin had not been detected at the time of the Institute of Medicine report in 2004, an IOM committee proposed a global subsidy high in the distribution chain, both to make ACTs inexpensive and to displace art Artemisinin monotherapy and other ineffective drugs. Expand
...
1
2
3
4
5
...